ArticleCell reports2022
Genome-wide CRISPR screen reveals v-ATPase as a drug target to lower levels of ALS protein ataxin-2.
Garam Kim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it
ArticleCell reports2022
Garam Kim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.